Use of tumour bed boost radiotherapy in volume replacement oncoplastic breast surgery: a systematic review

Emanuele Garreffa, Icro Meattini , Charlotte E Coles et al.
Use of tumour bed boost radiotherapy in volume replacement oncoplastic breast surgery: a systematic review
Like

Share this post

Choose a social network to share with, or copy the shortened URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Tumour bed boost radiotherapy (RT) following breast conserving surgery reduces local recurrence in high-risk disease. There is recent debate over challenges to accurately localise tumour bed for RT boost delivery following volume replacement oncoplastic breast surgery (VR-OBS).

This review evaluates the reporting of RT boost following VR-OBS in the literature published between January 2010 and December 2021. This review was in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (PRISMA).

Nine studies met the inclusion criteria (n = 670 patients), and RT boost was used in eight studies. Boost was administered in total to 384 patients (62.5% of irradiated patients). Only two studies reported boost planned target volumes and only one compared these against surgical specimen volumes. RT boost was not reported in most published studies on VR-OBS.

Future prospective research is strongly needed to evaluate long-term outcomes of VR-OBS following RT boost, especially on breast cosmesis and patients' satisfaction.

Read the full study here: Use of tumour bed boost radiotherapy in volume replacement oncoplastic breast surgery: A systematic review - PubMed (nih.gov)

Please sign in or register for FREE

If you are a registered user on ARBS Network, please sign in